Ibnsina Pharma (EGX:ISPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
10.61
-0.09 (-0.84%)
At close: Aug 14, 2025

Ibnsina Pharma Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
68,07355,84233,94922,26421,73318,679
Upgrade
Revenue Growth (YoY)
61.82%64.49%52.48%2.45%16.35%12.52%
Upgrade
Cost of Revenue
62,44151,44631,43420,64820,10317,212
Upgrade
Gross Profit
5,6324,3972,5151,6171,6301,467
Upgrade
Selling, General & Admin
2,3671,9311,2891,076829.22822.71
Upgrade
Other Operating Expenses
-40.51-7.71-9.46-7--
Upgrade
Operating Expenses
2,6052,1391,3641,135962.17978.17
Upgrade
Operating Income
3,0262,2581,152482.22667.35488.69
Upgrade
Interest Expense
-2,292-1,686-1,044-477.09-284.18-255.32
Upgrade
Interest & Investment Income
-0.2----
Upgrade
Currency Exchange Gain (Loss)
34.2855.3538.5338.410.28-0.3
Upgrade
Other Non Operating Income (Expenses)
86.1471.67121.65131.0186.0156.73
Upgrade
EBT Excluding Unusual Items
854.67698.77267.75174.55469.46289.8
Upgrade
Gain (Loss) on Sale of Investments
1.561.56-1.13---
Upgrade
Gain (Loss) on Sale of Assets
2.952.951.390.754.252.42
Upgrade
Legal Settlements
-----48-
Upgrade
Other Unusual Items
-----0.37-
Upgrade
Pretax Income
859.18703.28268.02175.31425.34292.22
Upgrade
Income Tax Expense
77.4188.7254.744.43110.9567.56
Upgrade
Earnings From Continuing Operations
781.77614.56213.27170.87314.4224.66
Upgrade
Minority Interest in Earnings
-00.391.710.33-
Upgrade
Net Income
781.77614.56213.66172.58314.73224.66
Upgrade
Preferred Dividends & Other Adjustments
74.66116.7740.5236.9528.440.55
Upgrade
Net Income to Common
707.11497.8173.14135.63286.33184.11
Upgrade
Net Income Growth
157.79%187.63%23.80%-45.16%40.09%-31.67%
Upgrade
Shares Outstanding (Basic)
1,1311,0081,0081,0081,3021,120
Upgrade
Shares Outstanding (Diluted)
1,1311,0081,0081,0081,3021,120
Upgrade
Shares Change (YoY)
12.21%---22.58%16.25%-
Upgrade
EPS (Basic)
0.630.490.170.130.220.16
Upgrade
EPS (Diluted)
0.630.490.170.130.220.16
Upgrade
EPS Growth
156.54%187.51%27.65%-38.81%33.78%-31.67%
Upgrade
Free Cash Flow
-3,668-1,185-228.23-436.58-487.9621.75
Upgrade
Free Cash Flow Per Share
-3.24-1.18-0.23-0.43-0.380.02
Upgrade
Dividend Per Share
----0.086-
Upgrade
Gross Margin
8.27%7.87%7.41%7.26%7.50%7.85%
Upgrade
Operating Margin
4.45%4.04%3.39%2.17%3.07%2.62%
Upgrade
Profit Margin
1.04%0.89%0.51%0.61%1.32%0.99%
Upgrade
Free Cash Flow Margin
-5.39%-2.12%-0.67%-1.96%-2.25%0.12%
Upgrade
EBITDA
3,1832,3911,266596.27784.78601.49
Upgrade
EBITDA Margin
4.67%4.28%3.73%2.68%3.61%3.22%
Upgrade
D&A For EBITDA
156.47133.16114.18114.04117.43112.8
Upgrade
EBIT
3,0262,2581,152482.22667.35488.69
Upgrade
EBIT Margin
4.45%4.04%3.39%2.17%3.07%2.62%
Upgrade
Effective Tax Rate
9.01%12.62%20.42%2.53%26.08%23.12%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.